Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach

Introduction: Multidrug resistance (MDR) is primarily associated with reduced intracellular drug accumulation owing to overexpression of p-glycoprotein, an active efflux transporter. Competitive inhibition or allosteric modulation of p-glycoprotein may alter the pharmacokinetics of the drugs that se...

Full description

Bibliographic Details
Main Authors: Chandana Roy, Pratiti Ghosh
Format: Article
Language:English
Published: Shahrekord University of Medical Sciences 2023-04-01
Series:Journal of HerbMed Pharmacology
Subjects:
Online Access:http://herbmedpharmacol.com/PDF/jhp-12-241.pdf
_version_ 1797839593916071936
author Chandana Roy
Pratiti Ghosh
author_facet Chandana Roy
Pratiti Ghosh
author_sort Chandana Roy
collection DOAJ
description Introduction: Multidrug resistance (MDR) is primarily associated with reduced intracellular drug accumulation owing to overexpression of p-glycoprotein, an active efflux transporter. Competitive inhibition or allosteric modulation of p-glycoprotein may alter the pharmacokinetics of the drugs that serve as substrates, resulting in enhanced drug bioavailability and tissue penetration. This study endeavors to assess the efficacy of the components of reno-protective herbs in the inhibition of p-glycoprotein activity thereby enhancing the possibility of the retention of co-administered renal medications inside the target cells. Methods: Drug-likeness and pharmacokinetic properties were determined to ensure the safety and efficacy of herbal constituents. Molecular docking employing the CDOCKER module of Discovery Studio was performed to investigate the binding affinity between the active constituents and the p-glycoprotein receptor (6C0V). Molecular dynamics simulation was utilized to further assess the stability of the complex of receptors with the component bearing its maximal affinity. Results: The analyses suggested that the inhibitors viz., atisine, kutkin, and embelin from Aconitum heterophyllum, phylloquinone from Calendula officinalis, stigmasterol from Paederia foetida, and convallamarogenin from Convallaria majalis demonstrated maximum binding affinity towards p-glycoprotein. Conclusion: Atisine may thus be identified as the lead compound in the augmentation of drug bioavailability inside the cell, along with its reno-protective efficacy.
first_indexed 2024-04-09T16:00:32Z
format Article
id doaj.art-374ea25d7862479a99bd1c0ae4f50987
institution Directory Open Access Journal
issn 2345-5004
language English
last_indexed 2024-04-09T16:00:32Z
publishDate 2023-04-01
publisher Shahrekord University of Medical Sciences
record_format Article
series Journal of HerbMed Pharmacology
spelling doaj.art-374ea25d7862479a99bd1c0ae4f509872023-04-25T12:41:55ZengShahrekord University of Medical SciencesJournal of HerbMed Pharmacology2345-50042023-04-0112224124910.34172/jhp.2023.26jhp-44751Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approachChandana Roy0Pratiti Ghosh1Department of Physiology, West Bengal State University, Kolkata-700126, IndiaDepartment of Physiology, West Bengal State University, Kolkata-700126, IndiaIntroduction: Multidrug resistance (MDR) is primarily associated with reduced intracellular drug accumulation owing to overexpression of p-glycoprotein, an active efflux transporter. Competitive inhibition or allosteric modulation of p-glycoprotein may alter the pharmacokinetics of the drugs that serve as substrates, resulting in enhanced drug bioavailability and tissue penetration. This study endeavors to assess the efficacy of the components of reno-protective herbs in the inhibition of p-glycoprotein activity thereby enhancing the possibility of the retention of co-administered renal medications inside the target cells. Methods: Drug-likeness and pharmacokinetic properties were determined to ensure the safety and efficacy of herbal constituents. Molecular docking employing the CDOCKER module of Discovery Studio was performed to investigate the binding affinity between the active constituents and the p-glycoprotein receptor (6C0V). Molecular dynamics simulation was utilized to further assess the stability of the complex of receptors with the component bearing its maximal affinity. Results: The analyses suggested that the inhibitors viz., atisine, kutkin, and embelin from Aconitum heterophyllum, phylloquinone from Calendula officinalis, stigmasterol from Paederia foetida, and convallamarogenin from Convallaria majalis demonstrated maximum binding affinity towards p-glycoprotein. Conclusion: Atisine may thus be identified as the lead compound in the augmentation of drug bioavailability inside the cell, along with its reno-protective efficacy.http://herbmedpharmacol.com/PDF/jhp-12-241.pdfmultidrug resistanceefflux transporterbiological availabilityherbsdocking
spellingShingle Chandana Roy
Pratiti Ghosh
Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
Journal of HerbMed Pharmacology
multidrug resistance
efflux transporter
biological availability
herbs
docking
title Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
title_full Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
title_fullStr Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
title_full_unstemmed Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
title_short Co-administration of herbal inhibitors of P-glycoprotein with renal drugs enhance their bioavailability– In silico approach
title_sort co administration of herbal inhibitors of p glycoprotein with renal drugs enhance their bioavailability in silico approach
topic multidrug resistance
efflux transporter
biological availability
herbs
docking
url http://herbmedpharmacol.com/PDF/jhp-12-241.pdf
work_keys_str_mv AT chandanaroy coadministrationofherbalinhibitorsofpglycoproteinwithrenaldrugsenhancetheirbioavailabilityinsilicoapproach
AT pratitighosh coadministrationofherbalinhibitorsofpglycoproteinwithrenaldrugsenhancetheirbioavailabilityinsilicoapproach